Outcomes for efavirenz versus nevirapine-containing regimens for treatment of HIV-1 infection: a systematic review and meta-analysis.
<h4>Introduction</h4>There is conflicting evidence and practice regarding the use of the non-nucleoside reverse transcriptase inhibitors (NNRTI) efavirenz (EFV) and nevirapine (NVP) in first-line antiretroviral therapy (ART).<h4>Methods</h4>We systematically reviewed virologi...
Guardado en:
Autores principales: | Prinitha Pillay, Nathan Ford, Zara Shubber, Rashida A Ferrand |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/55a36864f1364dd9a9098df1f671fdff |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Association between social psychological status and efavirenz and nevirapine plasma concentration among HIV patients in Kenya
por: Musa Otieno Ngayo, et al.
Publicado: (2021) -
Clinical utility and consumer considerations for the use of once-daily nevirapine extended release for HIV infection treatment
por: Pefura Yone EW, et al.
Publicado: (2012) -
Comparison of nevirapine plasma concentrations between lead-in and steady-state periods in Chinese HIV-infected patients.
por: Huijuan Kou, et al.
Publicado: (2013) -
International Normalized Ratio (INR) Increases amongst Two Patients Living with HIV on Warfarin after Being Switched from a Nevirapine to a Dolutegravir-Based Antiretroviral Regimen
por: Natalie Sang, et al.
Publicado: (2021) -
Effect on growth of exposure to maternal antiretroviral therapy in breastmilk versus extended infant nevirapine prophylaxis among HIV-exposed perinatally uninfected infants in the PROMISE randomized trial.
por: Lynda Stranix-Chibanda, et al.
Publicado: (2021)